The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience
Author:
- D. B. BrettlerDBD. B. Brettler
- 1 June 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 149 (6) , 1381-1385
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Efficacy of porcine factor VIII in the management of haemophiliacs with inhibitorsBritish Journal of Haematology, 1984
- Use of Porcine Factor VIII in the Management of Seventeen Patients with Factor VIII AntibodiesThrombosis and Haemostasis, 1984
- CLINICAL-EXPERIENCE WITH POLYELECTROLYTE-FRACTIONATED PORCINE FACTOR-VIII CONCENTRATE IN THE TREATMENT OF HEMOPHILIACS WITH ANTIBODIES TO FACTOR-VIII1984
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980